Company

Creo Medical Limited

Headquarters: Chepstow, United Kingdom

Employees: 217

CEO: Mr. Craig Jonathan Gulliford

LSE: CREO -0.71%

Market Cap

£166.2 Million

GBP as of Jan. 1, 2024

US$211.6 Million

Market Cap History

Creo Medical Limited market capitalization over time

Evolution of Creo Medical Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Creo Medical Limited

Detailed Description

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Creo Medical Limited has the following listings and related stock indices.


Stock: LSE: CREO wb_incandescent

Details

Headquarters:

Unit 2, Creo House

Beaufort Park Beaufort Park Way

Chepstow, NP16 5UH

United Kingdom

Phone: 44 1291 606005